In the BioHarmony Drug Report Database

"Preview" Icon

Clobazam

Onfi, Sympazan (clobazam) is a small molecule pharmaceutical. Clobazam was first approved as Onfi on 2011-10-21. It is used to treat lennox gastaut syndrome and seizures in the USA. Onfi’s patent is valid until 2024-04-03 (FDA).

 

Trade Name

 

Onfi, Sympazan
 

Common Name

 

clobazam
 

ChEMBL ID

 

CHEMBL70418
 

Indication

 

lennox gastaut syndrome, seizures
 

Drug Class

 

Benzodiazepine

Image (chem structure or protein)

Clobazam structure rendering